



















Surgical treatment of endometriosis 
before gamete intrafallopian transfer 
(GIFT)
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Objective. To determine whether active pelvic endometriosis impairs the efficacy of GIFT (gamete intrafallopian 
transfer) and whether prior surgical treatment of endometriosis improves the efficacy of GIFT.
Design. Matched controlled retrospective study. 
Setting. University-based assisted reproduction programme.
Patients. Patients who had GIFT between 1990 and 1997 were included in the study. Female patients 
were laparoscopically diagnosed as having endometriosis. Patients who did not have surgical treatment for 
endometriosis before GIFT were staged for endometriosis during the GIFT laparoscopy. Two patients, with 
no signs of endometriosis, were matched for every endometriosis case, and served as controls. Patients were 
matched for age, number of eggs transferred and percentage of normal sperm morphology. 
Intervention. Patients in 80 cycles had surgical treatment for endometriosis and 128 patients had GIFT 
procedures as treatment for endometriosis-related infertility. 
Main outcome measures. Ongoing pregnancies and deliveries. 
Statistical analysis. A Mantel-Haenszel approach was used to estimate relative risk of pregnancy outcome in 
the endometriosis groups versus controls. 
Results. There was a 22.9% pregnancy rate (11/48) among patients with active endometriosis who had GIFT 
procedures, versus a 37.0% pregnancy rate (37/100) for the controls, giving a relative risk of 0.62 (95% confidence 
interval (CI): 0.35 - 1.10, p = 0.082). There was a 36.3% pregnancy rate (29/80) among patients who had surgical 
treatment for endometriosis before GIFT, versus a 33.3% pregnancy rate (53/159) for the controls, giving a relative 
risk of 1.07 (95% CI: 0.75 - 1.54, p = 0.647). 
Conclusion. There is an indication that GIFT pregnancy rates are impared in patients suffering from active 
endometriosis, while prior surgery may alleviate the impairment.
Various mechanisms have been proposed to explain 
endometriosis-related infertility, the most important 
being mechanical factors, hostile peritoneal 
environment, altered systemic immune response, 
ovulatory dysfunction, early pregnancy loss and altered 
sperm-oocyte interaction.
In the case of women with endometriosis little is 
known about the effect of peritoneal fluid on the 
functional aspects of spermatozoa leading to sperm-
oocyte binding, fertilisation embryo development and 
implantation. It has been shown that laparoscopic 
resection or ablation of minimal and mild endometriosis 
enhances fecundity in infertile women.1 
Gamete intrafallopian transfer (GIFT) has been 
suggested as a treatment modality for endometriosis 
where patients have patent tubes.2 The aim of this 
retrospective matched control study was to compare 
pregnancy rate in patients treated with GIFT after 
endometriosis had been surgically removed, with 
the pregnancy rate in patients who had no surgical 
treatment for endometriosis before GIFT. 
Material and methods 
A retrospective analysis of patients with endometriosis 
was done from our computer database. All patients had 
an infertility history of more than 1 year. According to 
the data, 128 patients had GIFT procedures as treatment 
for endometriosis-related infertility. Their ages ranged 
from 21 to 40 years. The severity of endometriosis was 
staged according to the classification of the American 











Society for Reproductive Medicine (ASRM) into mild 
endometriosis (ASRM stages I and II), or severe 
endometriosis (ASRM stages III and IV). Of the 128 
GIFT cycles analysed, patients in 80 cycles had surgical 
treatment for endometriosis before GIFT was done. The 
endometriosis lesions were either removed surgically 
or cauterised using the argon beam coagulator. In 48 
cycles, patients did not have surgical treatment for 
their endometriosis before GIFT treatment. The stage 
of endometriosis in these patients was determined and 
graded at GIFT laparoscopy. In order to accommodate 
for differences in the husbands’ semen parameters, 
sperm morphology was evaluated according to the 
Tygerberg strict criteria3-5 and subdivided into two 
groups: (i) normal sperm morphology of < 4% (P-pattern 
– poor prognosis); and (ii) normal sperm morphology 
> 5% (G-pattern – good prognosis). The number of 
cycles in the P-pattern sperm morphology group in all 
the categories was too small for statistical evaluation 
and were therefore not analysed separately. The post-
preparation sperm count of all the men included in the 
study was > 1 x 106/ml.3,5 At the time of GIFT 500 000 
sperm with good motility after preparation were placed 
in the fallopian tube, where possible with no more than 
3 metaphase II (MII) oocytes.6 
The group that had previous surgery for endometriosis 
and the group with no previous surgery were matched 
with patients who had a GIFT procedure performed 
during the same time period (within 3 months that 
patients in the study group were done), serving as 
controls for each test subject. These controls were 
carefully matched according to the woman’s age, the 
number of oocytes transferred and also according to the 
husband’s normal sperm morphology.
Patients were stimulated with clomiphene citrate (CC) 
and human menopausal gonadotropin (HMG), or GnRH 
agonist and HMG. The ongoing pregnancy rate (> 28 
weeks’ gestation) in each group was determined as an 
end point.
Statistical methods 
A Mantel-Haenszel approach was used to estimate 
relative risk of pregnancy outcome in the comparison 
of the endometriosis groups versus the controls. The 
stratification used was either endometriosis stage or 
endometriosis stage by morphology. This choice was 
determined by the small number of patients in the P-
pattern morphology group. The stratification used is 
indicated for each comparison.
Results
One hundred and twenty-eight endometriosis-related 
GIFT procedures were analysed. Eighty patients (80 
cycles, Table I, group A) had had surgical treatment for 
endometriosis before the GIFT procedure. In 48 cycles 
(Table I, group B) a GIFT procedure was performed for 
patients who had no previous surgical treatment for 
endometriosis. The control group for group A included 
159 GIFT cycles (Table II, group C), and the control 
group for group B included 100 GIFT cycles (Table II, 
group D).
In 72 GIFT treatment cycles all the women had prior 
surgical treatment for endometriosis, and in 46 cycles 
the women had no prior treatment, with their husbands’ 
normal sperm morphology classified as G-pattern (Table 
I). The matched controls (Table II) for the surgically 
treated patients in the G-pattern morphology group 
consisted of 144 GIFT cycles (group C) and 96 GIFT 
cycles for the untreated group (group D).
The pregnancy rate in the active endometriosis group 
was 22.9% (Table I, group B) while the pregnancy rate 
in the respective control group was 37% (Table II, 
group D). The relative risk was estimated as 0.62 (95% 
confidence interval (CI): 0.35 - 1.10, p = 0.082) adjusting 
for endometriosis stage only.
The treated endometriosis group (group A) had a 
pregnancy rate of 36.3% compared with 33.3% for 
their respective controls (group C). The relative risk 
was estimated as 1.07 (95% CI: 0.75 - 1.54, p = 0.647) 
adjusting for endometriosis stage by morphology in 
three strata (stratum 1: stage I, II and G-pattern; 
stratum 2: stage III, IV and G-pattern; and stratum 3: 
stage I, II, III, IV and P-pattern).
There was no statistically significant difference 
between the 22.9% pregnancy rate obtained in the 
active endometriosis group (group B) compared with a 
combination of the selected control groups (33.3% and 
                                     Group A                                       Group B
                     Endometriosis treated (N = 80)                       Active endometriosis (N = 48)
Stage by morphology  Ongoing pregnancy (N (%)) Stage by morphology  Ongoing pregnancy (N (%)) 
G-pattern* (N = 72)     G-pattern (N = 46)
   Stage I, II† (N = 39)                     16 (41)      Stage I, II (N = 26)                   6 (23)
   Stage III, IV (N = 33)                     11 (33)      Stage III, IV (N = 20)                   5 (25)
P-pattern (N = 8)                        P-pattern (N = 2)
   Stage I, II (N = 4)                       1 (25)      Stage I, II (N = 2)                   0 (0)
   Stage III, IV (N = 4)                       1 (25)       Stage III, IV (N = 0)                   
      Total (N = 80)                     29 (36.3)         Total (N = 48)                 11 (22.9)
*Morphology category: G = good prognosis, P = poor prognosis.
†Grade of endometriosis:  I, II = mild; III, IV = severe.
Table I.     Pregnancy rates in treated and untreated endometriosis patients by endometriosis stage and 
morphology category




















37%) and the treated endometriosis group (36.3%). The 
relative risk was estimated as 0.64 (95% CI: 0.39 - 1.04, 
p = 0.074) adjusting for endometriosis stage by 
morphology in three strata (similar to the comparison 
of groups A and C). When performing a one-sided 
evaluation for the same data, testing the alternative 
hypothesis that the active endometriosis group would 
be negatively affected with regard to pregnancy 
outcome compared with the treated and control groups, 
a significant effect was detected (p = 0.047).
Of the 159 pregnancies in this study, 40 resulted 
in spontaneous abortions (25.2%), and 130 ongoing 
pregnancies were obtained, all of which resulted in live 
births. The abortion rate did not differ significantly among 
the different groups: group A 28.9%, group B 28.6%, 
control group C 21.2%, and control group D 27.1%.
Discussion
Evidence from the randomised controlled trial by 
Marcoux et al.,1 supported by 5 cohort studies and 
1 quasi-randomised trial, points to the effectiveness 
of surgical ablation of mild/minimal disease as a 
primary treatment option for improving infertility.7 It 
is more difficult to recommend the correct approach 
to infertility in patients with more severe disease 
because of lack of randomised controlled studies. 
However, surgical approach to treatment seems to be 
the best option. The Canadian Consensus Conference 
on Endometriosis8 was of the opinion that severe 
categories of endometriosis may be associated with 
a lower probability of pregnancy success. In women 
with milder disease, GIFT produced pregnancy rates 
that were similar to those in women with unexplained 
infertility.8 The lower GIFT pregnancy rate in the active 
endometriosis group compared with the matched 
control groups correlated with the finding by Guzick 
et al.9 In their matched case control GIFT study they 
reported a delivery rate of 23.7% per cycle compared 
with 22.9% (11/48) in our study. Furthermore, they 
reported a delivery rate of 35.5% in their control group 
compared with 36.3% (29/80) in our endometriosis-
treated group, and 34.7% (90/259) in our combined 
control groups.
The absence of a relationship between the severity of 
endometriosis and pregnancy rates may be owing to an 
inadequate power in our sample. The higher pregnancy 
rate in the endometriosis group that had surgical 
treatment before GIFT may strengthen the view of 
Guzick et al.9 that if the fallopian tubes are normal then 
the important parameter might simply be the presence 
or absence of endometriosis independent of severity.
Other factors that could have influenced pregnancy 
outcome in this study are the number and maturity 
of oocytes transferred10 and semen parameters,10,11 but 
these differences were carefully controlled for by the 
matching process. Also important is the observation 
that once patients were pregnant, the presence or 
absence of endometriosis did not seem to make any 
difference as the miscarriage rate among the groups 
was not significantly different.
The statistical estimates indicate a relative reduction 
of 36% in the pregnancy rate of women with active 
endometriosis versus selected and non-selected 
controls. However, based on this trend and the 
evidence obtained from the literature, we would argue 
that endometriosis-related infertility must be treated 
surgically before GIFT.
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 Group C                                    Group D
  Matched controls for endometriosis treated patients  Matched controls for active endometriosis patients   
                                   (N = 159)                                    (N = 100)
Stage by morphology  Ongoing pregnancy (N (%)) Stage by morphology  Ongoing pregnancy (N (%))
G-pattern* (N = 144)     G-pattern (N = 96)
   Stage I, II† (N = 76)                    30 (39)      Stage I, II (N = 54)                 23 (42.6)
   Stage III, IV (N = 68)                    22 (32)      Stage III, IV (N = 42)                 12 (28.6)
P-pattern (N = 15)     P-pattern (N = 4)
   Stage I, II (N = 10)                      0 (0)       Stage I, II (N = 2)                   2 (100)
   Stage III, IV (N = 5)                      1 (20)      Stage III, IV (N = 2)                   0 (0)
      Total (N = 159)                    53 (33.3)         Total (N = 100)                 37 (37)
*Morphology category: G = good prognosis, P = poor prognosis.
†Grade of endometriosis: I, II = mild; III, IV = severe.
Table II.     Pregnancy rates in the matched control patients for the treated and untreated endometriosis 
groups by endometriosis stage and morphology category.
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